Memorial Şişli Hospital
Memorial Şişli Hospital
Turchia, Istanbul
Betul Tavil
29 anni di esperienza
accreditamenti :
Clinica certificata da :
| Turchia | Austria | Spagna | |
| Terapia con cellule staminali per la malattia di Alzheimer | da $15,000 | da $40,000 | da $20,000 |
Dr. Bugra Bilge Keseroglu specializes in robotic and laparoscopic urology. His robotic work includes radical prostatectomy (conventional and Retzius-sparing), radical cystectomy, sacrocolpopexy, and Burch colposuspension. His laparoscopic work includes radical prostatectomy with lymph node dissection, radical cystectomy, sacrocolpopexy, and Burch colposuspension. He also performs laparoscopic nephrectomy and partial nephrectomy, pyeloplasty, all endourological surgeries (stone surgery and endoscopic procedures), HOLEP, and female incontinence surgery.
Education: Uludağ University Faculty of Medicine, 1990–1996. Specialization: S.B. Ankara Training and Research Hospital, 1997–2002. Experience: Yozgat State Hospital, 2002–2006 and 2012–2016; Yozgat Private Hospital, 2006–2011; S.B. Ankara Training and Research Hospital, 2016–2019; Bilkent City Hospital, 2019–2024.
Assoc. Prof. Dr. Necati Kaplan is a neurosurgeon specializing in brain, spine, and peripheral nerve surgery. He treats tumors, vascular disorders, hydrocephalus, trauma, degenerative spine disease, pediatric neurosurgical conditions, and Chiari malformation. He also works with experimental stem cell and exosome therapies.
He graduated from Cerrahpaşa Faculty of Medicine in 2000. He completed training in Minimally Invasive Neurosurgical Techniques in Mainz/Tuttlingen in 2016. He also trained in Advanced Neuroendoscopy (2004), the Keyhole concept (2003), Microsurgery at GATA (2005), Pediatric Neurosurgery (2015), and minimally invasive lumbar surgery (2015).
He has served as a Board Member of the Association of Nervous System Surgery since 2018. He is a member of the Turkish Neurosurgical Association (since 2008) and the Association of Stem Cell and Cellular Therapies (since 2019). He co-authored series on vertebroplasty (111 patients/140 segments), 200 anterior cervical surgeries, 271 lumbar microdiscectomies, 673 mild head trauma cases, and stem cell therapies.
Stem cell therapy cannot cure Alzheimers disease as it remains in experimental stages. While clinical trials show the treatment is generally safe, no regulatory agency has approved it to reverse the condition. Research focuses on using mesenchymal stem cells to reduce brain inflammation rather than replacing lost neurons.
Bookimed Expert Insight: Documentation matters more than marketing for this procedure. Leading centers like Liv Hospital Ulus use internal GMP-standard laboratories to ensure cell quality. Patients should verify if the facility has Turkish Ministry of Health approval for specific clinical trials. High-quality packages often include 16 days of hotel stay to monitor the post-therapy adaptation phase.
Patient Consensus: Many families describe seeking treatment as buying hope. While some report brief cognitive improvements, these often fade within six months without sustained long-term changes.
Stem cell therapy for Alzheimer's in Turkey primarily utilizes allogeneic mesenchymal stem cells derived from umbilical cord tissue, known as Wharton's jelly. These GMP-produced cells are often administered intrathecally or intravenously to target neuroinflammation and support potential neural tissue regeneration in JCI-accredited facilities.
Bookimed Expert Insight: Data from Liv Hospital Ulus shows a transition toward using only GMP-produced cells from Turkey's first private hospital stem cell center. While many expect autologous cells, clinics here favor umbilical cord-derived MSCs because these donor cells are often more potent and biologically active than a patient's own aged cells.
Patient Consensus: Patients often note that clinics may suggest switching from autologous to donor cells for higher potency. Many emphasize the importance of following a strict neuroplasticity-focused protocol, including nutritional support, alongside the cell injections.
Stem cell therapy for Alzheimer's in Turkey is generally considered safe for elderly patients when performed in JCI-accredited facilities. Using minimally invasive intravenous or intrathecal injections avoids the high risks of general anesthesia or major surgery. Specialized centers utilize GMP-certified mesenchymal stem cells to ensure biological safety and reduce inflammatory responses.
Bookimed Expert Insight: While many search for the lowest cost, the 16-night hotel inclusion at clinics like Liv Hospital Ulus is a critical safety differentiator. This extended period ensures elderly patients stabilize after cellular therapy before enduring the physiological stress of a long-haul flight home.
Patient Consensus: Families emphasize securing medical clearance from a home cardiologist before traveling. They also stress ensuring consent forms and procedure risks are explained clearly in the patient native language.
Patients typically observe subtle cognitive improvements 3 to 6 months after stem cell therapy for Alzheimer's in Turkey. Peak regenerative effects generally manifest around 12 months post-injection, as mesenchymal stem cells work to reduce neuroinflammation and support neural repair protocols within JCI-accredited facilities.
Bookimed Expert Insight: Data from Liv Hospital Ulus shows that combining GMP-standard stem cells with 16-night recovery stays optimizes monitoring. Prof. Erdal Karaöz uses multi-dose protocols because repeated exposure often yields more consistent neurological stabilization than a single infusion. This structured approach helps manage the initial inflammatory phase effectively.
Patient Consensus: Patients emphasize that gains like remembering names or improved mood are gradual. Real-world experiences suggest using objective tools like MoCA scores to track these subtle improvements rather than relying on daily impressions.
Top Turkish clinics for Alzheimer’s stem cell therapy include JCI-accredited facilities like Liv Hospital Ulus and Memorial Şişli Hospital. These centers utilize mesenchymal stem cells (MSCs) and Good Manufacturing Practice (GMP) certified laboratories to provide regenerative treatments under specialized neurological protocols in Istanbul.
Bookimed Expert Insight: While many clinics offer single-dose treatments, the most established Turkish programs like Liv Hospital Ulus emphasize multi-dose protocols (up to 3 doses) paired with extended 16-day recovery stays. This long-term monitoring approach is a significant differentiator compared to standard outpatient infusions seen in other regions.
Patient Consensus: Patients emphasize the importance of tracking MoCA scores and consulting independent neurologists, as these therapies are currently considered palliative and outcomes vary significantly between cases.
Leading specialists for Alzheimer's stem cell therapy in Turkey include cellular therapy researchers and neurosurgeons operating in GMP-standard facilities. Key figures like Professor Erdal Karaoz at Liv Hospital Ulus and Associate Professor Necati Kaplan lead clinical trials using mesenchymal stem cells processed in specialized laboratory environments.
Bookimed Expert Insight: While many neurosurgeons offer stem cell infusions, the most advanced results come from specialists who control their own laboratory environments. Professor Erdal Karaoz at Liv Hospital Ulus manages one of the few clinics with an integrated GMP lab, ensuring cell viability and precise 2-to-3 dose protocols that are rarely matched by smaller outpatient centers.
Patient Consensus: Families emphasize targeting credible researchers like Professor Erdal Karaoz but warn that cognitive improvements may be temporary. Many advise coordinating with a home neurologist to monitor memory scores and setting realistic expectations for short-term clarity rather than a permanent cure.
Medical travelers in Istanbul typically spend $50 to $150 per night for standard hotels, while high-end recovery environments range from $160 to $200. Many clinics, particularly for stem cell therapy, bundle 16 days of hotel stay into premium packages to ensure proper post-treatment monitoring.
Bookimed Expert Insight: While daily rates seem low, stem cell therapy often requires 16-day recovery windows. Choosing premium packages at centers like Liv Hospital Ulus is more cost-effective because they include the full 16-night hotel stay and VIP transfers, which would otherwise add $1,200 to $2,000 to your independent travel budget.
Patient Consensus: Travelers suggest booking apartments with kitchens in Şişli or Nişantaşı to save 50% compared to hotels. Many advise negotiating 20–30% discounts directly with hosts for stays exceeding two weeks.